Elevated Cldn expression level, particularly Cldn3/4, has been reported in various types of solid cancer (e.g., PC, ovarian, breast, prostate and colon cancer) [41,42,43,44,45,46]. This evidence concerns the gene CLDN3 and pachyonychia congenita.